12:00 AM
 | 
Feb 17, 2011
 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/ pathway Summary Licensing status Publication and contact information
Cancer
Lymphoma MAP kinase kinase kinase 14 (MAP3K14; NIK);...

Read the full 168 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >